Tylenol-maker shares sink after report says RFK's HHS will link to autism

Core Viewpoint - Shares in Kenvue, the parent company of Tylenol-maker McNeil Consumer Healthcare, experienced a significant decline of over 14% following a report indicating a potential link between Tylenol and autism, as suggested by HHS Secretary Robert F. Kennedy Jr. [1][3] Group 1: Company Impact - Kenvue's shares plunged more than 14% in Friday afternoon trading due to the report [3] - The report is expected to be released this month and may highlight the risks associated with Tylenol taken during pregnancy [1] Group 2: Product Information - Tylenol is widely used for pain relief, fever reduction, and treating various symptoms, with acetaminophen as its active ingredient [2] - The medical community has previously deemed acetaminophen-containing products safe for pregnant women [2]